BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
Stifel 2016 Healthcare Conference
Tuesday, November 15, 2016
10:15 a.m. Eastern Standard Time
Jefferies 2016 Global Healthcare Conference
Thursday, November 17, 2016
5:20 p.m. Greenwich Mean Time
About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.